Malin Andersson
Affiliations: | 1998-2002 | Department of Pharmaceutical Biosciences | Uppsala University, Uppsala, Uppsala län, Sweden |
Google:
"Malin Andersson"Mean distance: 17.2 (cluster 11)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kononenko O, Bazov I, Watanabe H, et al. (2016) Opioid precursor protein isoform is targeted to the cell nuclei in the human brain. Biochimica Et Biophysica Acta |
| Bergman HM, Lundin E, Andersson M, et al. (2016) Quantitative mass spectrometry imaging of small-molecule neurotransmitters in rat brain tissue sections using nanospray desorption electrospray ionization. The Analyst |
| Karlsson O, Bergquist J, Andersson M. (2014) Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA). Molecular & Cellular Proteomics : McP. 13: 93-104 |
| Ljungdahl A, Hanrieder J, Bergquist J, et al. (2013) Analysis of neuropeptides by MALDI imaging mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 1023: 121-36 |
| Hanrieder J, Ekegren T, Andersson M, et al. (2013) MALDI imaging of post-mortem human spinal cord in amyotrophic lateral sclerosis. Journal of Neurochemistry. 124: 695-707 |
| Karlsson O, Berg AL, Lindström AK, et al. (2012) Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus. Toxicological Sciences : An Official Journal of the Society of Toxicology. 130: 391-404 |
| Hanrieder J, Ljungdahl A, Andersson M. (2012) MALDI imaging mass spectrometry of neuropeptides in Parkinson's disease. Journal of Visualized Experiments : Jove |
| Lindgren HS, Rylander D, Iderberg H, et al. (2011) Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia. Journal of Parkinson's Disease. 1: 347-57 |
| Ljungdahl A, Hanrieder J, Fälth M, et al. (2011) Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease. Plos One. 6: e25653 |
| Hanrieder J, Ljungdahl A, Fälth M, et al. (2011) L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry. Molecular & Cellular Proteomics : McP. 10: M111.009308 |